EP Patent

EP1177807A2 — Device and method of creating aerosolized mist of respiratory drug

Assigned to Aradigm Corp · Expires 2002-02-06 · 24y expired

What this patent protects

A drug delivery device, comprising: a channel having a first opening into which air can be inhaled and a second opening from which a patient can withdraw air; a mechanism for applying physical force to formulation upon actuation; and an air-heating device which adds energy…

USPTO Abstract

A drug delivery device, comprising: a channel having a first opening into which air can be inhaled and a second opening from which a patient can withdraw air; a mechanism for applying physical force to formulation upon actuation; and an air-heating device which adds energy to air inhaled into the channel;    wherein the device is a hand-held self-contained device having a total weight of 1 kilogram or less.

Drugs covered by this patent

Patent Metadata

Patent number
EP1177807A2
Jurisdiction
EP
Classification
Expires
2002-02-06
Drug substance claim
No
Drug product claim
No
Assignee
Aradigm Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.